Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

October 01, 2008 (Vol. 28, No. 17)

Opinion: Reining In New Therapeutic Hype Is Critical

Finding the Middle Ground Between Biotech Executive Optimism and Practitioner Pessimism

  • In the April 2008 issue of BioExecutive International , Hagen et al., noted that “in presentations by biotech executive investors, seldom is presented a discouraging word.” In the article, the authors encouraged these executives to translate their enthusiasm into language the investment community (which would include larger pharmaceutical licensing ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.